Literature DB >> 29541829

[Clinical and pathological characteristics of intravascular lymphomas].

L Abraham1, H Kreipe1, P Raab2, K Hussein3.   

Abstract

Intravascular B‑cell lymphomas (IVL) are rare neoplasms that can manifest at any age (mean age ~62-63 years). About half of the cases are associated with Epstein-Barr virus. The most common sites of manifestation are the brain, skin, and bone marrow. The diagnosis is difficult due to unspecific clinical presentation and laboratory changes. FACS (fluorescence-activated cell sorting) and clonality analysis from peripheral blood and radiological findings are often not diagnostic. The most sensitive and most specific diagnostic method is the histopathological and immunohistochemical evaluation of a tissue biopsy. Because of the rarity of this disease, little is known about therapy and prognosis, whereby therapy is mainly similar to non-IVL lymphomas. The prognosis is poor; median survival after diagnosis is approximately one year.

Entities:  

Keywords:  Histology; Immunohistochemistry; Intravascular lymphoma; Neuroradiology

Mesh:

Year:  2018        PMID: 29541829     DOI: 10.1007/s00292-018-0427-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  45 in total

1.  An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.

Authors:  T Murase; S Nakamura; K Kawauchi; H Matsuzaki; C Sakai; T Inaba; K Nasu; K Tashiro; T Suchi; H Saito
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Epstein-Barr virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient.

Authors:  C H Hsiao; I J Su; S W Hsieh; S F Huang; T F Tsai; M Y Chen; S W How
Journal:  Am J Surg Pathol       Date:  1999-04       Impact factor: 6.394

3.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Elías Campo; Fabio Facchetti; Luca Mazzucchelli; Tadashi Yoshino; Takuhei Murase; Stefano A Pileri; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Shigeo Nakamura
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

4.  CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.

Authors:  María José Moreno; Rosa Bosch; Rebeca Dieguez-Gonzalez; Silvana Novelli; Ana Mozos; Alberto Gallardo; Miguel Ángel Pavón; María Virtudes Céspedes; Albert Grañena; Miguel Alcoceba; Oscar Blanco; Marcos Gonzalez-Díaz; Jorge Sierra; Ramon Mangues; Isolda Casanova
Journal:  J Pathol       Date:  2014-12-11       Impact factor: 7.996

5.  High Frequency of Bone Marrow Involvement in Intravascular Large B-Cell Lymphoma.

Authors:  Jianchao Wang; Wenshuang Ding; Limin Gao; Wenqing Yao; Min Chen; Sha Zhao; Weiping Liu; Wenyan Zhang
Journal:  Int J Surg Pathol       Date:  2016-09-24       Impact factor: 1.271

6.  Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations.

Authors:  R M Stroup; K Sheibani; A Moncada; L J Purdy; H Battifora
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

7.  HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma.

Authors:  Genevieve M Crane; Richard F Ambinder; Courtney M Shirley; Elliot K Fishman; Yvette L Kasamon; Janis M Taube; Michael J Borowitz; Amy S Duffield
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

8.  HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma.

Authors:  Judith A Ferry; Aliyah R Sohani; Janina A Longtine; Robert A Schwartz; Nancy L Harris
Journal:  Mod Pathol       Date:  2009-03-13       Impact factor: 7.842

Review 9.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

10.  Unusual manifestation of intravascular large B-cell lymphoma: severe hypercalcemia with parathyroid hormone-related protein.

Authors:  Jung Min Ha; Eun Kim; Woo Joo Lee; Ji-Won Hwang; Sehyo Yune; Young Hyeh Ko; Joon Young Choi; Seok Jin Kim; Won Seog Kim
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.